| Patient category | |||||||
---|---|---|---|---|---|---|---|---|
REF | PC | AC | SIH | IIH | iNPH | Comm. HC | Non-comm. HC | |
Number of subjects | 28 | 13 | 14 | 14 | 15 | 63 | 11 | 3 |
Ith dose of gadobutrol | ||||||||
 0.10 mmol | 0 | 0 | 0 | 0 | 0 | 13 | 0 | 0 |
 0.25 mmol | 3 | 0 | 2 | 4 | 1 | 17 | 3 | 0 |
 0.50 mmol | 25 | 13 | 12 | 10 | 14 | 33 | 8 | 3 |
Gender (male/female) | 6/22 | 1/12 | 8/6a | 5/9 | 2/13 | 37/26b | 7/4a | 2/1 |
Age (years) | 39 ± 12 | 36 ± 13 | 52 ± 17a | 50 ± 10b | 33 ± 11 | 72 ± 6c | 49 ± 13a | 43 ± 29 |
Height (cm) | 172 ± 8 | 170 ± 5 | 176 ± 10 | 172 ± 10 | 165 ± 7b | 173 ± 9 | 178 ± 12 | 171 ± 7 |
Weight (kg) | 82 ± 15 | 80 ± 15 | 82 ± 13 | 78 ± 23 | 88 ± 17 | 81 ± 16 | 84 ± 20 | 80 ± 24 |
BMI (kg/m2) | 28 ± 5 | 28 ± 4 | 27 ± 3 | 26 ± 6 | 32 ± 5a | 27 ± 4 | 26 ± 5 | 27 ± 6 |
GFR (ml/min) | 103 ± 12 | 98 ± 12 | 86 ± 16b | 95 ± 15 | 105 ± 13 | 77 ± 14c | 92 ± 18 | 104 ± 15 |